about
Integrative analysis of kinase networks in TRAIL-induced apoptosis provides a source of potential targets for combination therapyClinical significance of DAPK promoter hypermethylation in lung cancer: a meta-analysis.Synthesis of 6,8,9 poly-substituted purine analogue libraries as pro-apoptotic inducers of human leukemic lymphocytes and DAPK-1 inhibitors.Tumour suppressor death-associated protein kinase targets cytoplasmic HIF-1α for Th17 suppression.Clinical effect of DAPK promoter methylation in gastric cancer: A systematic meta-analysis.Quantitative and correlation analysis of the DNA methylation and expression of DAPK in breast cancer.JunD/AP-1 Antagonizes the Induction of DAPK1 To Promote the Survival of v-Src-Transformed Cells.Tumor suppression and promotion by autophagyDevelopment of all-in-one multicistronic Tet-On lentiviral vectors for inducible co-expression of two transgenes.Aberrant methylation and expression of DAPk1 in human hypopharyngeal squamous cell carcinoma.Promoter methylation of tumor-related genes as a potential biomarker using blood samples for gastric cancer detection.Comparison of Selected Protein Levels in Tumour and Surgical Margin in a Group of Patients with Oral Cavity Cancer.Comparative Protein Interaction Network Analysis Identifies Shared and Distinct Functions for the Human ROCO Proteins.Restoration of DAP Kinase Tumor Suppressor Function: A Therapeutic Strategy to Selectively Induce Apoptosis in Cancer Cells Using Immunokinase Fusion Proteins.Evaluation of the prognostic and physiological functions of death associated protein kinase 1 in breast cancer.
P2860
Q28115758-3670CE36-67E8-4876-B9B7-EBE9FDDD6164Q35229048-B5D88B4D-0C85-4428-B354-0215104D8DFAQ35598395-0B8671BD-4CED-47C8-9C0F-0F410EBE1427Q37024230-35A9A136-7117-49E1-859B-04B26FC96AC4Q37384082-F0A8EC87-56BD-4BD4-AD0A-4065C6370EC5Q37705217-6D28A95E-2EFE-427F-9744-347E4BF355B2Q39235186-925CB588-7491-46E9-A301-2B90CA4C5CA1Q42136875-65D22003-0457-4845-89DE-5A9FEC80A027Q42218909-9FBE8126-5CE3-4959-A1FA-E9D17E48E8A0Q43629270-D23CF512-35E8-4104-984B-0C068B1CE13AQ47146471-472A7F6B-9A39-4FCD-A512-C2D935DAB926Q51050113-C9C83E6F-408E-41DF-BCCB-A2416A122999Q51765180-33E1338F-5466-409E-99F4-D5663B72232EQ51793176-A2543D0D-9593-4B6A-8ADE-AC4A2D728920Q54978013-F6F559A6-20EC-4437-B89D-4912CCF410EC
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Evaluating DAPK as a therapeutic target.
@en
type
label
Evaluating DAPK as a therapeutic target.
@en
prefLabel
Evaluating DAPK as a therapeutic target.
@en
P2093
P2860
P1433
P1476
Evaluating DAPK as a therapeutic target
@en
P2093
P2860
P2888
P304
P356
10.1007/S10495-013-0919-2
P50
P577
2014-02-01T00:00:00Z